Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.
Journal: Clinical breast cancer
Published: February 01, 2021
NCCN Guidelines Insights: Antiemesis, Version 2.2017.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2017
Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.
Journal: The breast journal
Published: February 08, 2017
Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is New.
Journal: Clinical breast cancer
Published: December 19, 2014
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.
Journal: Clinical Medicine Insights. Oncology
Published: August 31, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026